| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0090-6980(02)00111-9 |
| P8608 | Fatcat ID | release_yo3sanhcjnbxfiuemx2ra6bzhm |
| P698 | PubMed publication ID | 12428674 |
| P50 | author | Michael Mullan | Q41779102 |
| Demian Obregon | Q115617259 | ||
| P2093 | author name string | Daniel Paris | |
| James Humphrey | |||
| Kirk P Townsend | |||
| P2860 | cites work | Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis | Q24646764 |
| Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease | Q24670696 | ||
| Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles | Q28242608 | ||
| Inhibition of Alzheimer's beta-amyloid induced vasoactivity and proinflammatory response in microglia by a cGMP-dependent mechanism | Q28374458 | ||
| Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease | Q29617986 | ||
| Inflammation of the brain in Alzheimer's disease: implications for therapy. | Q33594683 | ||
| Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline | Q33895797 | ||
| COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex | Q37691478 | ||
| The effect of age on cyclooxygenase-2 gene expression: NF-kappaB activation and IkappaBalpha degradation | Q38313494 | ||
| Role of the beta-amyloid protein in Alzheimer's disease. | Q40615436 | ||
| Mediators of injury in neurotrauma: intracellular signal transduction and gene expression | Q40965329 | ||
| Amyloid beta-protein and the genetics of Alzheimer's disease | Q41074945 | ||
| Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. | Q41749781 | ||
| Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons | Q42491893 | ||
| The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition | Q42494371 | ||
| Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid | Q42829876 | ||
| Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles | Q45103797 | ||
| The primary structure of p38 gamma: a new member of p38 group of MAP kinases | Q46763189 | ||
| p38 kinase is activated in the Alzheimer's disease brain | Q48227440 | ||
| Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains | Q48298397 | ||
| Inflammatory molecule release by beta-amyloid-treated T98G astrocytoma cells: role of prostaglandins and modulation by paracetamol | Q48333373 | ||
| Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. | Q48556921 | ||
| Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. | Q52884779 | ||
| Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. | Q53189340 | ||
| Elevated CSF prostaglandin E2 levels in patients with probable AD. | Q53342107 | ||
| Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study | Q57782164 | ||
| Native Nicotinic Acetylcholine Receptors in Human Imr32 Neuroblastoma Cells: Functional, Immunological and Pharmacological Properties | Q62946671 | ||
| NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro | Q72321250 | ||
| Isolation and characterization of cerebral resistance vessel endothelium in culture | Q72322111 | ||
| Elevated CSF prostaglandin E2 levels in patients with probable AD | Q73114348 | ||
| Novel strategies for opposing murine microglial activation | Q73374890 | ||
| Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide | Q73514544 | ||
| SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes | Q77303079 | ||
| A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA | Q77669505 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 1-12 | |
| P577 | publication date | 2002-09-01 | |
| P1433 | published in | Prostaglandins and Other Lipid Mediators | Q15754476 |
| P1476 | title | Pro-inflammatory effect of freshly solubilized beta-amyloid peptides in the brain | |
| P478 | volume | 70 |
| Q37630535 | Activated astrocytes: a therapeutic target in Alzheimer's disease? |
| Q38066233 | Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade. |
| Q37640235 | Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases |
| Q46836622 | Cyclooxygenase (COX)-1 activity precedes the COX-2 induction in Aβ-induced neuroinflammation |
| Q47295950 | Decursin attenuates the amyloid-β-induced inflammatory response in PC12 cells via MAPK and nuclear factor-κB pathway. |
| Q43406863 | Ethanol extract of Magnolia officinalis prevents lipopolysaccharide-induced memory deficiency via its antineuroinflammatory and antiamyloidogenic effects |
| Q89746353 | Extracellular vesicle-mediated amyloid transfer to neural progenitor cells: implications for RAGE and HIV infection |
| Q40389352 | Extracellular vesicles of the blood-brain barrier: Role in the HIV-1 associated amyloid beta pathology. |
| Q38659874 | Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology |
| Q33604503 | HIV-1 stimulates nuclear entry of amyloid beta via dynamin dependent EEA1 and TGF-β/Smad signaling |
| Q39769825 | HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin |
| Q42044152 | Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: a potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease |
| Q40580069 | Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production |
| Q24803797 | Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease |
| Q33828792 | Microsomal prostaglandin E synthase-2: cellular distribution and expression in Alzheimer's disease |
| Q34774194 | Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease |
| Q37317769 | Simvastatin protects against amyloid beta and HIV-1 Tat-induced promoter activities of inflammatory genes in brain endothelial cells |
| Q38005630 | The role of inflammatory processes in Alzheimer's disease. |
Search more.